Abstract:OBJECTIVE:To study clinicopathologic features, diagnosis, treatment and prognosis of von Hippel-Lindau (VHL) syndrome-related and sporadic hemangioblastomas of the central nervous system (CNS-HB).METHODS:Histopathological, ultrastructural, immunohistochemical (EnVision method) and clinical features of 21 VHL syndrome and 63 sporadic CNS-HB cases were studied with correlation of the available follow-up information.RESULTS:Twenty-one VHL patients accompanied with a total of 87 CNS-HBs, including one patient of developing 12 HBs within 13 years. There were 10 patients presenting other lesions related to VHL, including 6 retinal HBs, 4 pancreatic tumors (endocrine tumor and microcystic cystadenoma), 1 clear renal cell carcinoma, 4 renal cysts and 1 endolymphatic sac tumor. One patient developed 5 different tumors related to VHL within a period of 4 years. In the 63 cases of sporadic CNS-HB (34 male and 29 female), the mean age was 43.0 years. Among the 18 VHL syndrome patients with available follow-up information, 14 were still alive and within them, 4 became disabled and 11 had developed new lesions. The other 4 patients died. Among the 42 patients of sporadic HB with follow-up information, 39 were alive including 3 disabled cases, and the other 3 died. Histologically, the tumors showed large and vacuolated stromal cells. Some tumors showed atypical nuclei. Involvement of the brain tissue was seen in 32 cases, among which, 21 patients with available follow-up information were learnt to be alive. Tumor cells of HB stained positive for vimentin, EGFR, Inhibin alpha and D2-40, but negative for CD34 and CD68. In 3 cases of HB, some stromal cells were positive for GFAP. All cases showed a low expression for Ki-67, except 2 cases with 2% and 1 case with 5% Ki-67 indices.CONCLUSIONS:VHL syndrome is a multisystem disorder with a poor prognosis and a high rate of missed diagnosis. The syndrome is characterized by development of various benign and malignant tumors. The most common tumor is CNS-HB, which occurs predominantly in the cerebellum. Patients with VHL syndrome tend to present at a younger age than patients with sporadic CNS-HBs, and VHL related HB occurs more predominantly in the brain stem and spinal cord. Prognosis of CNS-HB patients is not correlated with the nuclear atypicality, expression for Ki-67 and involvement of the brain tissue. Because new lesions may develop during the patient's lifetime. So that, regular clinical inspection is recommended in order to check up the development of any new lesions.

Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.

Clinical and genetic investigation of a multi-generational Chinese family afflicted with Von Hippel-Lindau disease.

Identification of a VHL Gene Mutation in a Chinese Family with Von Hippel‑Lindau Syndrome.

Genetic Study of a Large Chinese Kindred with Von Hippel-Lindau Disease.

Germline mutation and clinical prognostic analysis of VHL gene in familial central nervous system hemangioblastoma

Germline mutations in the VHL gene associated with 3 different renal lesions in a Chinese von Hippel-Lindau disease family

Large germline deletion of the VHL gene in Chinese families with von Hippel-Lindau syndrome

Epidemiological Study of a Von Hippel-Lindau Family in Northwest China

Clinicopathologic Study of Von Hippel-Lindau Syndrome-Related and Sporadic Hemangioblastomas of Central Nervous System

De Novo VHL Germline Mutation Detected in a Patient with Mild Clinical Phenotype of Von Hippel-Lindau Disease.

Central Nervous System Hemangioblastoma in a Pediatric Patient Associated With Von Hippel-Lindau Disease: A Case Report and Literature Review

[Familial and Genetic Study in a Large Chinese Kindred with Von Hippel-Lindau Disease and Gene Mutation Analysis].

Frequent Mutations of VHL Gene and the Clinical Phenotypes in the Largest Chinese Cohort With Von Hippel-Lindau Disease.

A Deletion Mutation of the VHL Gene Associated with a Patient with Sporadic Von Hippel-Lindau Disease.

Overexpression of EGFR and TGFα in Von Hippel–Lindau-Related Central Nervous System Hemangioblastomas

Novel Genotype-Phenotype Correlations in Five Chinese Families with Von Hippel-Lindau Disease.

Genetic Characterization and Protein Stability Analysis of a Chinese Family with Von Hippel-Lindau Disease.

Biological and Clinical Impact of Central Nervous System Hemangioblastomas in Chinese Patients with Von Hippel-Lindau Disease: Implications for Treatment

Preliminary Study of Whole-Genome Bisulfite Sequencing and Transcriptome Sequencing in VHL Disease-Associated Ccrcc.

Identification of a VHL gene mutation in atypical Von Hippel-Lindau syndrome: genotype–phenotype correlation and gene therapy perspective

Germline Mutations of the VHL Gene in Seven Chinese Families with Von Hippel-Lindau Disease